Survival and burden of cancer: A population-based analysis in a medium size city in Brazil

Ione Jayce Ceola Schneider,Eliane Traebert,Jefferson Traebert,Leandro Pereira Garcia,Paula Stefânia Da Mota De Souza Patrício Patrício,Rafael Aiello Bomfim,Rodrigo Dias Nunes,Tauana Prestes Schmidt

doi:10.33448/rsd-v10i5.15140

Abstract

Objective: The aim of this study was to estimate 5-year survival and the burden of cancer in a medium-sized city in Southern Brazil. Methods: A cohort study was performed using governmental data of incidence and mortality from cancer at Florianopolis/SC, Southern Brazil. Survival rates were performed using Kaplan Meier methods and log-rank test to compare curves. Disability-adjusted life years (DALY), years lived with disability (YLD) and years of life lost (YLL) and age-standardized rates of each indicator were estimated. Results: Thyroid, prostate and melanoma of skin had higher survival rates. Cancers presenting the highest burden, in decreasing order, were thyroid, prostate, breast, trachea, bronchus and lung, followed by colon and rectum. Conclusion: The estimates in local level could be help the health services to improve their quality. Highest burden was related to thyroid, prostate and breast due to the highest survival rates. Other cancer as trachea, bronchus and lung, and colon and rectum had high burden due to mortality.

Highlights

Cancer is one of the major health problems worldwide
The best 5-year-survival rates were found in thyroid (98.6%), testis (83.7%) and melanoma (83.7%) cancers
The worst 5-year-survival rates were found in other pharynx (18.8%), trachea, bronchus and lug (22.5%) and pancreas (23.1%) cancers a

Summary

Introduction

Cancer is one of the major health problems worldwide. In high income and some upper-middle income countries, recent evidences have shown that deaths from cancer are common causes of deaths in middle age (35 to 70 years), and probably will become the leading cause of death in some years (Dagenais et al, 2019). In 2008, 12,7 million cases of cancer were diagnosed worldwide. In 2013, that number increased to 14,9 million (Stewart & Wild, 2014) and in 2018, up to 17,0 million new cancer cases were diagnosed (Bray et al, 2018). In Brazil, 600 thousand new cases were estimated in 2018 (Santos, 2018). If no global interventions are performed, it is expected that in the two decades, mankind will have to deal with 25 million new cases of cancer annually (Stewart & Wild, 2014)

Methods

Results

Discussion

Conclusion